Joseph E. Parisi

Active 1982–2024

221
Papers
50,711
Citations
126
h-index
219
i10-index

Citations

Citations per year for Joseph E. Parisi1949: 1 citations1965: 1 citations1974: 1 citations1975: 1 citations1979: 1 citations1982: 1 citations1983: 2 citations1986: 1 citations1987: 2 citations1988: 3 citations1989: 4 citations1990: 4 citations1991: 1 citations1992: 10 citations1993: 11 citations1994: 15 citations1995: 32 citations1996: 43 citations1997: 68 citations1998: 84 citations1999: 95 citations2000: 94 citations2001: 134 citations2002: 170 citations2003: 211 citations2004: 237 citations2005: 253 citations2006: 344 citations2007: 447 citations2008: 494 citations2009: 576 citations2010: 587 citations2011: 690 citations2012: 660 citations2013: 655 citations2014: 598 citations2015: 552 citations2016: 609 citations2017: 714 citations2018: 539 citations2019: 1,780 citations2020: 1,759 citations2021: 1,642 citations2022: 1,340 citations2023: 886 citations2024: 1,429 citations2025: 717 citations2026: 32 citations1950–1964: no citations, so these years are not shown1966–1973: no citations, so these years are not shown1976–1978: no citations, so these years are not shown1980–1981: no citations, so these years are not shown1984–1985: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,739 citing papers, 29.9% of this breakdownUnited Kingdom: 2,137 citing papers, 9.5% of this breakdownGermany: 1,454 citing papers, 6.5% of this breakdownItaly: 1,185 citing papers, 5.3% of this breakdownCanada: 1,159 citing papers, 5.1% of this breakdownChina: 940 citing papers, 4.2% of this breakdownFrance: 789 citing papers, 3.5% of this breakdownNetherlands: 780 citing papers, 3.5% of this breakdownSpain: 736 citing papers, 3.3% of this breakdownAustralia: 696 citing papers, 3.1% of this breakdownSweden: 592 citing papers, 2.6% of this breakdownJapan: 590 citing papers, 2.6% of this breakdown
0%29.9%Other 20.9%

Fields

  • Medicine72.4%
  • Neuroscience15%
  • Biochemistry, Genetics and Molecular Biology8.9%
  • Immunology and Microbiology1%
  • Psychology0.6%
  • Computer Science0.5%
  • Other1.6%

Topics

  • Alzheimer's disease research and treatments10.6%
  • Dementia and Cognitive Impairment Research7.3%
  • Parkinson's Disease Mechanisms and Treatments5.5%
  • Multiple Sclerosis Research Studies5%
  • Amyotrophic Lateral Sclerosis Research3.4%
  • Neuroinflammation and Neurodegeneration Mechanisms3.3%
  • Other64.9%

Coauthors

All papers

Open in search
  1. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque

    Authors: , , , , , , , , , , , - Annals of Neurology 2015 cited by 710

  2. Multisite study of the relationships between antemortem [11C]PIB‐PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Salvatore Spina, Prashanthi Vemuri, Victor L. Villemagne, Melissa E. Murray, Gil D. Rabinovici - Alzheimer s & Dementia 2018 cited by 326

  3. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination

    Authors: , , , , , - Annals of Neurology 2000 cited by 3,340

  4. Cortical demyelination and diffuse white matter injury in multiple sclerosis

    Authors: , , , , , , , , - Brain 2005 cited by 1,830

  5. TDP-43 is a key player in the clinical features associated with Alzheimer’s disease

    Authors: , , , , , , , , , , , , , , , - Acta Neuropathologica 2014 cited by 487

  6. Inflammatory Cortical Demyelination in Early Multiple Sclerosis

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2011 cited by 1,086

  7. A large-scale comparison of cortical thickness and volume methods for measuring Alzheimer's disease severity

    Authors: , , , , , , , , , , , , , , - NeuroImage Clinical 2016 cited by 445

  8. Increased Risk of Type 2 Diabetes in Alzheimer Disease

    Authors: , , , , , - Diabetes 2004 cited by 956

  9. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease

    Authors: , , , , , , , - Annals of Neurology 1997 cited by 1,485

  10. Updated TDP-43 in Alzheimer’s disease staging scheme

    Authors: , , , , , , , , , - Acta Neuropathologica 2016 cited by 379

  11. Selective loss of cortical endothelial tight junction proteins during Alzheimer’s disease progression

    Authors: , , , , , , , , , , , , - Brain 2019 cited by 196

  12. Rates of hippocampal atrophy and presence of post-mortem TDP-43 in patients with Alzheimer's disease: a longitudinal retrospective study

    Authors: , , , , , , , , , , , , , - The Lancet Neurology 2017 cited by 253

  13. Staging TDP-43 pathology in Alzheimer’s disease

    Authors: , , , , , , , - Acta Neuropathologica 2013 cited by 373

  14. Dissecting phenotypic traits linked to human resilience to Alzheimer’s pathology

    Authors: , , , , , , , , , , , , , , , , , , , - Brain 2013 cited by 381

  15. An autoradiographic evaluation of AV-1451 Tau PET in dementia

    Authors: , , , , , , , , , , , , , , , , , , - Acta Neuropathologica Communications 2016 cited by 480

  16. Neuroimaging correlates of pathologically defined subtypes of Alzheimer's disease: a case-control study

    Authors: , , , , , , , , , , , - The Lancet Neurology 2012 cited by 440

  17. APOE3 -Jacksonville (V236E) variant reduces self-aggregation and risk of dementia

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kejal Kantarci, David S. Knopman, Val J. Lowe, Clifford R. Jack, Joseph E. Parisi, Tanis J. Ferman, Bradley F. Boeve, Neill R. Graff‐Radford, Ronald C. Petersen, Steven G. Younkin, John Denis Fryer, Hu Wang, Xianlin Han, Carl Frieden, Dennis W. Dickson, Owen A. Ross, Guojun Bu - Science Translational Medicine 2021 cited by 108

  18. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

    Authors: , , , , , , , , , , , , , , , , , , , - Brain 2007 cited by 952

  19. Subtypes of dementia with Lewy bodies are associated with α-synuclein and tau distribution

    Authors: , , , , , , , , , , , , , , , , , , - Neurology 2020 cited by 108

  20. Clinicopathologic correlations in 172 cases of rapid eye movement sleep behavior disorder with or without a coexisting neurologic disorder

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Dennis W. Dickson - Sleep Medicine 2013 cited by 391

  21. Clinicopathologic and11C-Pittsburgh compound B implications of Thal amyloid phase across the Alzheimer’s disease spectrum

    Authors: , , , , , , , , , , , , , , - Brain 2015 cited by 331

  22. Altered brain energetics induces mitochondrial fission arrest in Alzheimer’s Disease

    Authors: , , , , , , , , , , , , , , , - Scientific Reports 2016 cited by 206

  23. Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Neurobiology of Aging 2009 cited by 656

  24. Neuropathology of Cognitively Normal Elderly

    Authors: , , , , , , , , , , , , - Journal of Neuropathology & Experimental Neurology 2003 cited by 671